FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that it will deliver a presentation at the 27th Annual Canaccord Adams Global Growth Conference. Dr. Charles Hart, chief scientific officer, is scheduled to present to leading institutional investment representatives at 9:00 a.m. Eastern Time on August 8, 2007 at the Intercontinental Hotel in Boston, Mass.
